검색어 : 통합검색[659.1]
총 1,003건 중 1,000건 출력
, 9/100 페이지
-
81
- Restructuring Aid Granted Prior to the Accession of a Member State to the EU: ``Existing Aid'' under Article 1(b) of Regulation No. 659/1999?
- Stoycheva, I.; Papazova, M.; ; (European state aid law quarterly, v.12, 2013, pp.646-650)
-
82
- Criminal Justice in Hong Kong. By Carol Jones with Jon Vagg. London; New York: Routledge-Cavendish, 2007. Pp.xii, 659. ISBN: 978-1-84568-038-1. UK$40.00; US$90.00.
- Sturgeon, Roy L.; ; (International journal of legal information : IJLI : the official publication of the International Association of Law Libraries, v.36, 2008, pp.532-533)
-
83
- Comment on “Tunability of linear and nonlinear optical absorption in laterally coupled AlxGa<sup>1-<i>x</i> </sup>As/GaAs quantum wires” [J. Alloys Compd. 746 (2018) 653–659]
- Evangelou, Sofia; Corresponding author.; (Journal of alloys and compounds, v.850, 2021, pp.156302)
-
84
- TAK-659 in combination with NKTR-214 and anti-PD-1 therapy leads to complete and sustained tumor regression and immune memory in pre-clinical syngeneic models.
- Yu, Jie; Sappal, Jessica Huck; Zhang, Mengkun; Kannan, Karuppiah; Zalevsky, Jonathan; Takeda Pharmaceuticals, Cambridge, MA; ; Takeda Pharmaceuticals International Co, Cambridge, MA; ; Takeda Pharmaceuticals, Cambridge, MA, US; ; Takeda Pharmaceuticals Inc, Cambridge, MA; ; Nektar Therapeutics, San Francisco, CA; (Journal of clinical oncology : official journal of the American Society of Clinical Oncology, v.36, 2018, pp.2567-2567)
-
85
- X86서버 인기로 점진적 성장세 '유지' : 쿼드코어·블레이드·가상화 '인기'…오는 2010년 1조2천659억원 전망
- 장윤정; ; (Network times, v.173, 2008, pp.142-143)
-
86
- TAK‐659, AN INVESTIGATIONAL REVERSIBLE DUAL SYK/FLT‐3 INHIBITOR, IN PATIENTS WITH LYMPHOMA: UPDATED RESULTS FROM DOSE‐ESCALATION AND EXPANSION COHORTS OF a PHASE 1 STUDY
- Kaplan, J.; Gordon, L.; Infante, J.; Popat, R.; Rambaldi, A.; Madan, S.; Patel, M.R.; Gritti, G.; El‐ Sharkawi, D.; Chau, I.; Radford, J.; Perez De Oteyza, J.; Zinzani, P.; Iyer, S.; Faucette, S.; Sheldon‐ Waniga, E.; Stumpo, K.; Shou, Y.; Carpio, C.; Bosch, F.; Department of Medicine, Northwestern University, Chicago, USA; Robert H Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Chicago, USA; Drug Development Unit, Sarah Cannon Research Institute/Tennessee Oncology, Nashville, USA; NIHR Clinical Research Facility, UCLH, London, UK; Dipartimento di Oncologia ed Emato‐ Oncologia / Hematology and Bone Marrow Transplant Unit, Università degli Studi di Milano / Ospedale Papa Giovanni XXII, Bergamo, Italy; Dipartimento di Oncologia ed Emato‐ Oncologia/Hematology and Bone Marrow Transplant Unit, Università degli Studi di Milano/Ospedale Papa Giovanni XXIII, Bergamo, Italy; Hematology‐ Oncology, Florida Cancer Specialists/Sarah Cannon Research In; (Hematological oncology, v.35, 2017, pp.72-74)
-
87
- Mary John, <i>Children's Rights and Power: Charging up for a New Century</i>, Jessica Kingsley, London, 2003, 304 pp., £15.95 PB, ISBN: 1 85302 659 X
- AXFORD, NICK; ; (Journal of social policy, v.34, 2005, pp.167-169)
-
88
- Synthesis and Activity of a Metabolite of (S)-6-Amino-5- (6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxamido) -3-methyl-1-phenyl-2,4-(1H,3H)-pyrimidinedione (CX-659S).
- Isobe, Yoshiaki; Tobe, Masanori; Takahashi, Osamu; Goto, Yuso; Inoue, Yoshifumi; Obara, Fumihiro; Tsuchiya, Masami; Hayashi, Hideya; Pharm. Biotechnol. Lab., Japan Energy Corp., Toda, Saitama 335, Japan; Pharm. Biotechnol. Lab., Japan Energy Corp., Toda, Saitama 335, Japan; Pharm. Biotechnol. Lab., Japan Energy Corp., Toda, Saitama 335, Japan; Pharm. Biotechnol. Lab., Japan Energy Corp., Toda, Saitama 335, Japan; Pharm. Biotechnol. Lab., Japan Energy Corp., Toda, Saitama 335, Japan; Pharm. Biotechnol. Lab., Japan Energy Corp., Toda, Saitama 335, Japan; Pharm. Biotechnol. Lab., Japan Energy Corp., Toda, Saitama 335, Japan; Pharm. Biotechnol. Lab., Japan Energy Corp., Toda, Saitama 335, Japan; (Chem Inform, v.34, 2003, )
-
89
- TAK-659, a dual SYK/FLT3 inhibitor, leads to complete and sustained tumor regression and immune memory against tumor cells upon combination with anti-PD-1 agent
- Kannan, K.; Riley, J.; Zhang, M.; Farrell, P.; Bailey, B.; Creson, J.; Fujitani, Y.; Yu, J.; Huck, J.; ; (European journal of cancer, v.69, 2016, pp.S92)
-
90
- Radioisotopes in the diagnosis of diseases of the kidneys and urinary tract : (Eds. Timmermans and Merchie.) Excerpta Medical Foundation, 1969, 659 pp. £15. 1<I>s</I>. 0<I>d</I>.
- McCready, V.R.; ; (The International journal of applied radiation and isotopes, v.21, 1970, pp.633-634)
QUICK MENU
